Kalle Mattila
kalmat@utu.fi |
Publications 
2 of 4
- Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021 (2023)
- Therapeutic Advances in Urology
(A1 Refereed original research article in a scientific journal) - Paikallisesti edenneen ihomelanooman hoito ja ihomelanooman esiliitännäishoito (2023)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study (2023)
- Cancer Medicine
(A1 Refereed original research article in a scientific journal) - Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma (2023)
- Acta Dermato-Venereologica
(A1 Refereed original research article in a scientific journal) - Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor (2022)
- Acta Oncologica
(A1 Refereed original research article in a scientific journal) - Edenneen munuaissyövän hoito (2022)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Immuuniaktivaation vapauttajien, kaksoisspesifisten vasta-aineiden ja CAR-T-soluhoitojen sydänhaitat (2022)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Novel prognostic factors for advanced melanoma and localized renal cell carcinoma (2022) Mattila Kalle E.
(G5 Article dissertation ) - Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy (2022)
- Cancers
(A2 Refereed review article in a scientific journal ) - Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland (2022)
- Acta Dermato-Venereologica
(A1 Refereed original research article in a scientific journal)
UTU Research Portal